Article
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
1 Mar 2022
Abstract excerpt
New genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constantly emerge through unmitigated spread of the virus in the ongoing Coronavirus disease 2019 pandemic. Omicron (B.1.1.529), the latest variant of concern (VOC), has so far shown exceptional spread and infectivity and has established itself as the dominant variant in recent months. The SARS-CoV-2 spike glycoprotein is a key...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
